Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04249193
Other study ID # DDD603862
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2014
Est. completion date October 2017

Study information

Verified date March 2020
Source Christiana Care Health Services
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary purpose of this observational study was to determine if pRBC transfusions decrease the frequency of intermittent hypoxia events in very low birth weight infants (VLBW) during the first six weeks of life. The impact on non-pRBC transfusions on the frequency of intermittent hypoxia was also assessed.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date October 2017
Est. primary completion date October 2017
Accepts healthy volunteers
Gender All
Age group N/A to 6 Weeks
Eligibility Inclusion Criteria:

- 23+0 to 28+6 weeks gestational age at birth

Exclusion Criteria:

- Infants with life-limiting diagnoses

- Cyanotic heart disease

- In utero fetal transfusion

- Twin to twin transfusion syndrome

- Isoimmune hemolytic disease

- Severe acute hemorrhage

- Acute shock

- Sepsis with coagulopathy

- Need for perioperative transfusion

- Parents opposed to transfusion of blood

- Parents with hemoglobinopathy or congenital anemia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Transfusion
pRBC and non-pRBC transfusions

Locations

Country Name City State
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States Pennsylvania Hospital Philadelphia Pennsylvania
United States Temple University Hospital Philadelphia Pennsylvania

Sponsors (4)

Lead Sponsor Collaborator
Christiana Care Health Services Pennsylvania Hospital, Temple University Hospital, University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in number of Intermittent hypoxia An intermittent hypoxemia event is defined as a fall in oxygen saturations to less than 80% for >/= 10 secs and <3 minutes with a minimal time interval of 4 seconds between events. Change in number of intermittent hypoxia before (approximately 8 hours) and after transfusion (approximately 8 hours).
Secondary Hypoxia Percent time with oxygen saturations less than 85%, 80% and 75%. 8 hours prior to transfusion and 8 hours after transfusion.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03651154 - Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections N/A
Completed NCT01136590 - Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery Phase 4
Completed NCT00097006 - Retrovirus Epidemiology Donor Study-II (REDS-II) N/A
Completed NCT00005303 - Effectiveness of AIDS Antibody Screening N/A
Completed NCT00005319 - Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine N/A
Completed NCT00005301 - Transfusion Safety Study (TSS) N/A
Completed NCT00000581 - Granulocyte Transfusion Study Phase 3
Completed NCT04089865 - Oral Versus Intravenous Tranexamic Acid Phase 4
Completed NCT02968654 - TRansfusion Strategies in Acute Brain INjured Patients N/A
Enrolling by invitation NCT06019364 - Transfusion of Whole Blood in Acute Bleeding
Completed NCT04911413 - Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery Phase 4
Completed NCT03727230 - RhD+ Blood Transfusion to Asian-type DEL Recipients N/A
Recruiting NCT06102590 - Oxygen Extraction-guided Transfusion N/A
Completed NCT00400192 - Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury N/A
Completed NCT00000593 - Viral Activation Transfusion Study (VATS) N/A
Completed NCT05581238 - Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
Completed NCT05627544 - Blood Transfusion Applications in Hip Replacements
Not yet recruiting NCT03429790 - Cell Salvage During Caesarean Section (CSCS) N/A
Completed NCT00822588 - Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not N/A
Withdrawn NCT00269971 - A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery. Phase 3